shr-2017
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 4, 2023 (NCT05930704)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07028268 | Phase 2 | Jun 24, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06380881 | Phase 1 | May 20, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT05930704 | Phase 1 | Jul 4, 2023 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1